Welcome to Pharmer, the blog site with a distinct focus on pharmaceutical trends in Singapore & Asia. Our readers, meaning you, will be known as the pharmer, probably some one who is a current/future stakeholder in the pharmaceutical industry.
But why Asia?
- The pharmaceutical industry in the U.S. and Europe operates in a fiercely competitive environment,
- Difficult for life science companies to sustain their commercial and medical impact of their medicines on a global scale.
- Rising R&D cost, cost containment and generic pressures
Have persuaded many companies to tap the exciting potential of emerging markets in Asia.
——————————————————————————————-
DISCLAIMER:
This site is maintained by Pharmer who will be graduating from the National University Singapore in a couple of months and is a stakeholder in Singapore’s pharmaceutical industry. Writer does not guarantee the accuracy of postings and readers should evaluate all information presented in a critical and responsible manner. Whenever possible, writer will present information which are accurate and not falsified unless writer himself has been mislead by the source of information
